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Accepted 23 March 2020; Published online 27 March 2020AbstractObjective: Identify the current practice for recruitment prediction and monitoring within clinical trials.
Study Design and Setting: Chief investigators (CIs) were surveyed to identify data sources and adjustments made to support recruit-
ment prediction. Statisticians were surveyed to determine methods and adjustments used when predicting and monitoring recruitment. Par-
ticipants were identified from the National Institute for Health Research recently funded studies, the UK Clinical Research Collaboration
registered Clinical Trial Units network or by the European Clinical Research Infrastructure Network.
Results: A total of 51 CIs (UK 5 32, ECRIN 5 19) and 104 statisticians (UK 5 51, ECRIN 5 53) were contacted. Response rates
varied (CIs UK 5 53% ECRIN 5 32%; statisticians UK 5 98% ECRIN 5 36%).
Multiple data sources are used to support recruitment rates, most commonly audit data from multiple sites. Variation in individual site
recruitment rates are frequently incorporated, but staggered site openings were featured more commonly among UK respondents. Simple
prediction methods are preferred to rarely used statistical models. Lack of familiarity with statistical methods are barriers to their use with
evidence needed to justify the time required to support their implementation.
Conclusion: Simplistic methods will continue as the mainstay of prediction; however, generation of evidence supporting the benefits of
complex statistical models should promote their implementations. Multiple data sources to support recruitment prediction are being used,
and further work on the quality of these data is needed. Pressure to be optimistic about recruitment rates for the trial to be attractive to
funders was felt by a sizable minority.  2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC
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Clinical trials are a major financial investment with the
time to recruit to the required sample size being a key
driver of associated costs. Failure to successfully recruit
clinical trial participants as predicted at the design stage
has many negative consequences. These range from incur-
ring increased costs and time to answer the clinical question
of interest to abandoning the research with the question re-
maining unanswered. There may also be negative impact on
the planning and roll out of future research.
Despite investment aimed at reducing difficulties in
recruitment to clinical trials [1,2], there has been no demon-
strable improvement and 45% of trials supported by two
prestigious UK funding bodies, Health Technology Assess-
ment and Medical Research Council (HTA & MRC),
continue to fail to meet their original recruitment targets [3].ess article under the CC BY-NC-ND license (http://creativecommons.org/
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Key findings
Statistical models to predict recruitment are rarely
used. Uptake is limited by the absence of evidence
regarding their benefit over more simplistic ap-
proaches. Predictions allowed for variation in site
recruitment rates and staggered site openings,
whereas seasonal variation and holiday periods were
less frequently considered.
Respondents in European network had greater
awareness of statistical methods to predict recruit-
ment in comparison with the UK respondents; how-
ever, numbers are small, and the European sample
is subject to potential response bias.
Approximately, one-third of UK and half of the Eu-
ropean Clinical Research Infrastructure Network
(ECRIN) respondents in the Chief Investigators’ sur-
vey reported a need to be optimistic about the pre-
dicted recruitment rate, to be attractive to the funder.
What this adds to what is known?
Prediction of recruitment in clinical trials continues
to represent a formidable challenge. This survey iden-
tifies data sources and factors used to adjust recruit-
ment rates. It identifies that simplistic approaches to
predict recruitment are favored over more complex
statistical models. Barriers to uptake of the statistical
methods include complexity of their implementation
and absence of evidence that the time taken to imple-
ment them will result in improving the accuracy of
recruitment prediction.
What is the implication and what should change
now?
Evidence demonstrating superiority of statistical
methods over simplistic methods needs to be estab-
lished on a prospective cohort of trials. Subsequently,
relevant software and training courses should be
made available. Multiple data sources are being used,
and further work on the quality of this data is needed.
Balance of expectations between funders and appli-
cants needs further exploration.
A prioritization exercise was undertaken to identify un-
certainties related to trial recruitment as a focus for future
methodological research [4]. Recruitment prediction was
identified as a top 10 priority area. Despite the fact that
every clinical trial will require such predictions to be made,
little is known about how this is achieved either in terms of
data sources or methods used. This is unlikely to change
given that reporting requirements for recruitment within amain clinical trial article are minimal [5] and grant applica-
tions are generally not publicly available.
To determine current practice within the United
Kingdom and Europe, we undertook a survey of Chief In-
vestigators (CIs) and a survey of statisticians across a UK
and a European network.2. Methods
2.1. Design
EG led the design of each survey with input from all co-
authors. Questions targeted data sources and methods used
for recruitment prediction, identifying team members
contributing to the process, and awareness and implementa-
tion of the statistical models (statisticians survey only).
Multiple choice answers were informed by relevant publi-
cations about statistical models [6,7] and other approaches
that could be used for recruitment prediction and moni-
toring, as well as by a number of factors that impact recruit-
ment rate that should be considered [8e11].2.1.1. Chief investigators’ survey
The CIs’ survey targeted those collaborating within UK
and European research infrastructures. The survey aimed to
be brief to maximize return rates collecting information not
available from publicly available sources covering data
sources used to predict recruitment and how these were
applied to trial and site requirements. The survey was re-
viewed within the study team before circulation across
the UK and the European Clinical Research Infrastructure
Network (ECRIN, https://www.ecrin.org/).
A prize equivalent to £75 in vouchers was offered as an
incentive to participation. The full list of survey questions
and the invitation email are provided in the Additional
file 1.
2.1.1.1. UK chief investigators. UK CIs of recently
funded clinical trials were surveyed as identified from the
National Institute for Health Research (NIHR) journals li-
brary (https://www.journalslibrary.nihr.ac.uk/programmes/
hta/, searched in May and October 2018). The NIHR is
the largest funder of health and care research within the
United Kingdom. To be eligible for inclusion projects were
required to be randomized with the trial status listed as
‘‘waiting to start’’. CI details were obtained from the pro-
jects’ website and each contacted by EG via email, contain-
ing an invitation to participate and the survey attached as a
Word document. CIs were also given the option of dele-
gating completion to a trial team member. If no response
was obtained within 2 weeks then a reminder email was
sent and a further reminder followed 3 weeks later, within
which we gave them the option to answer the survey via a
phone call. A final attempt was made to contact nonrespon-
dents by phone to ensure the correct contact details.
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Network chief investigators. We surveyed CIs working in
collaboration with European Clinical Research Infrastruc-
ture Network (ECRIN), a nonprofit distributed infrastructure
that supports the conduct ofmultinational clinical research in
Europe. The ECRIN European Correspondents (EuCos),
based within each member or observer country, distributed
the survey within their respective countries. The survey
context and purpose was explained to the EuCos via a
Web-based meeting before contacting CIs of ECRIN-
supported studies via email. The email contained an invita-
tion to participate and the survey as an attached Word docu-
ment. Two reminders were sent to the EuCos requesting
recirculation of the survey.
2.1.2. Statisticians’ survey
We surveyed statisticians within UKCRC-registered
CTUs and ECRIN. The aim of the survey was to establish
current practice, and knowledge and implementation of
available statistical models. The survey was reviewed
within the study team and piloted with a senior statistician
before circulation across the UKCRC-registered CTU Sta-
tistics Group and ECRIN. A prize equivalent to £75 in
vouchers was offered as an incentive to participation.
The full list of questions for the online survey and the
invitation email are provided in the Additional file 1.
2.1.2.1. UK CTU Statisticians. The UKCRC-registered
CTU secretariat distributed the survey via email to the
nominated senior statistician within each registered CTU.
The email contained an invitation to participate and a link
to an online survey, which was constructed using
SelectSurvey.NET (http://selectsurvey.net/). The statistician
could discuss responses within the wider statistical team of
their CTU, but only a single response per CTU was
required. Email reminders were sent after 1, 2, and 4 weeks.
Nonrespondents also had the opportunity to respond by
completion of a paper copy of the survey distributed during
the UKCRC-registered CTU Statistics Operational Group
Network statisticians meeting in October 2018.
2.1.2.2. ECRIN Statisticians. The EuCos at ECRIN circu-
lated the email invitation with the link to the online survey
to the statisticians identified within their national network.
The same procedure was followed as for the CIs’ survey
with the EuCos sending two reminders.
2.2. Analysis
Quantitative data from closed-ended questions were
analyzed using RStudio, version 3.5.0 [12]. Due to the
restricted sample sizes, statistical testing was not planned
and results are reported as frequencies and percentages.
EG, SD, and CG reviewed responses to open-ended ques-
tions identifying themes within the free text answers and
categorized them in groups.3. Results
3.1. Chief investigators’ survey
The CIs’ survey was conducted between 24 October
2018 and 30 November 2018 within the United Kingdom
and between 18 October 2018 and 8 March 2019 within
ECRIN with results summarized in Table 1. A total of 32
studies were identified as eligible for inclusion in the UK
cohort, and 17 responses were received (53%) from the
CIs contacted. Two CIs completed the survey twice each al-
lowing for the multiple trials which they led as the CI.
Nineteen studies were identified via the ECRIN EuCos with
six responses (32%) received.
The data source most commonly used to predict trial
recruitment was audit data from across multiple sites with
the impact of specific eligibility criteria being the most
frequently adjusted factor (Table 1, Question 1). Although
no respondents reported adjusting for ethnic minorities,
one respondent elaborated that not adjusting for this factor
negatively impacted their predictions.
Allowing for variation in recruitment rates at individual
sites was also common (13/17 UK, 6/6 ECRIN) with com-
ments supporting the need for this practice based on varia-
tion in patient numbers and knowledge of site research
activity infrastructure and experience. The majority of
UK respondents (15/17, 88%) did not assume that all sites
would be open for the same length of time in comparison
with only one of the six ECRIN respondents (17%). Free
text responses reported staggered opening times to reflect
variation in time required at each site to obtain approvals.
Eleven (65%) UK respondents searched a trial registry for
competing trials compared with 100% of ECRIN respon-
dents (Table 1, Question 6). Thirty-five percent of UK and
fifty percent of ECRIN respondents were aware of other trials
competing to recruit the same patient population. Co-enrol-
ment was considered for only half of UK and one-third of
ECRIN respondents. One-third of UK and half of ECRIN re-
spondents reported a need to be optimistic about the pre-
dicted recruitment rate for the trial to be attractive to the
funder. Free text comments highlighted the difficulties this
practice would lead to during trial conduct. Additional com-
ments stated that the estimates were reflective of recruit-
ments rates if things went well, accepting that this may not
be the case with an inability to accurately predict researcher
performance and stability of local clinical services.
3.2. Statisticians’ survey
The survey was conducted between 18 September 2018
and 6 November 2018 among the 51 UKCRC-registered
CTUs of whom 50 (98%) responded (46 responses
completed online, four responses completed at the network
meeting). The ECRIN EuCos circulated the survey between
13 November 2018 and 29 January 2019 to 53 participants
of whom 19 (36%) responded.
Table 2 summarizes the survey results.
Table 1. Survey results of the Chief Investigators’ survey (UK & ECRIN)
Question Answers
UK
N [ 17 ECRIN N [ 6 Overall N [ 23
n (%) n (%) n (%)
1) In determining the disease or condition
prevalence, what sources of data were
available to you to use? Please select all that
apply.
Population-based data on geographical areas
covered by sites
9 (53) 5 (83) 14 (61)
Disease/condition incidence data 8 (47) 6 (100) 14 (61)
Audit data from a single site 5 (29) 3 (50) 8 (35)
Audit data from multiple sites 14 (82) 4 (67) 18 (78)
Estimates obtained from sites based on their
experience/perceptions rather than available
data
5 (29) 3 (50) 8 (35)
Feasibility or pilot study 5 (29) 3 (50) 8 (35)
Previous RCTs in similar populations 7 (41) 4 (67) 11 (48)
Other: Please specifya 4 (24) 1 (17) 5 (22)
2) In considering the translation of these data
sources to your trial population which of the
following adjustments did you make within
your grant application to predict recruitment
in to your study? Please select all that apply.
Estimated impact of specific eligibility
criteria
15 (88) 6 (100) 21 (91)
Ethnic minorities 0 (0) 0 (0) 0 (0)
Seasonal effects 4 (24) 2 (33) 6 (26)
Consent rate 13 (76) 3 (50) 16 (70)
Other: Please specifyb 6 (35) 1 (17) 7 (30)
None 1 (6) 0 (0) 1 (4)
3) Within your trial’s recruitment period, did you
assume that all sites would be open for the
same length of time?
Yes 2 (12) 5 (83) 7 (30)
No: Please specify 15 (88) 1 (17) 16 (70)
4) Within your trial’s recruitment period, did you
assume that all sites would have the same
average recruitment rate?
Yes 4 (24) 0 (0) 4 (17)
No: Please specify 13 (76) 6 (100) 19 (83)
5) In considering recruitment to your trial, were
you aware of any trials recruiting at the same
time that would compete for the same patient
population?
Yes: Please specify any strategy used to
allow for the impact on your recruitment
6 (35) 3 (50) 9 (39)
No 11 (65) 3 (50) 14 (61)
6) Did you search a trial registry for competing
trials?
Yes 11 (65) 6 (100) 17 (74)
No 6 (35) 0 (0) 6 (26)
7) Is your trial open to coenrollment (e.g., patient
enrollment to more than one trial)?
Yes: If yes, what restrictions apply? 9 (53) 2 (33) 11 (48)
No 8 (47) 4 (67) 12 (52)
8) In estimating your recruitment rate, there may
be a need to be optimistic about your
recruitment rate for the trial to be attractive to
the funder. Do you feel that this issue
impacted the recruitment rate used?
Yes 6 (35) 3 (50) 9 (39)
No 11 (65) 3 (50) 14 (61)
a Local patient survey; data compiled by a specific NIHR biomedical research unit; national data on disease activity; multiple sources.
b Difficulties in recruiting; logistics of recruitment; availability of research nurses; data on rates of recruitment from previous studies; a general
rule: 50% of what the Principal Investigator estimates; eligible Vs consent rate, e.g., we expect the recruitment to be something between 30 and
50% of the eligible population depending on the trial question; impact of recruiters.
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n (%) n (%) n (%)
Introductory questions
1) Who usually leads recruitment prediction for a
clinical trial within your unit? Please select all
that apply.
Chief investigator 33 (66) 13 (68) 46 (67)
Trial coordinator 28 (56) 5 (26) 33 (48)
Statistician 29 (58) 10 (53) 39 (57)
Other (e.g., IT team, senior staff) 6 (12) 1 (5) 7 (10)
2) Do you believe a statistician should be involved
in the recruitment prediction process?
Yes 43 (86) 13 (68) 56 (81)
No 3 (6) 6 (32) 9 (13)
3) When predicting the recruitment rate at the
pretrial planning stage, where do you find the
information about the prevalence of the
condition being studied, the eligibility of
patients, the consent rate of participants etc.?
Please provide informationa
Published literature 28 (56) 10 (53) 38 (55)
Research team experience 28 (56) 10 (53) 38 (55)
Previous studies 22 (44) 4 (21) 26 (38)
Registry data/audit data/patient databases/hospital
data
22 (44) 5 (26) 27 (39)
Feasibility surveys/pilot studies/sites’ questionnaire 24 (48) 5 (26) 29 (42)
Conservative interpretation of previous experience or
consent rate
4 (8) 0 (0) 4 (6)
PPIb engagement group 2 (4) 0 (0) 2 (3)
Projections were not particularly evidence based 1 (2) 0 1 (1)
NA 0 (0) 1 (5) 1 (1)
4) In considering recruitment to trials in your
CTU, are you usually confident that you are
aware of other trials recruiting at the same time
that would compete for the same patient
population?
Not confident at all 0 (0) 1 (5) 1 (1)
Not very confident 6 (12) 11 (58) 17 (25)
Neither 10 (20) 1 (5) 11 (16)
Fairly confident 28 (56) 5 (26) 33 (48)
Very confident 6 (12) 1 (5) 7 (10)
Recruitment prediction
5) In addition to the number of patients and the
number and size of sites, what factors would
you routinely consider when predicting rates of
recruitment? Please select all that apply.
Staggered site openings 48 (96) 13 (68) 61 (88)
Seasonal variation 24 (48) 9 (47) 33 (48)
Holiday periods 21 (42) 9 (47) 30 (43)
Other 9 (18) 6 (32) 15 (22)
6) Do you use any statistical model for
recruitment prediction?
Yes 3 (6) 4 (21) 7 (10)
No 47 (94) 15 (79) 62 (90)
7) Are you aware of any of the statistical
approaches listed below for use in recruitment
prediction? Please select all that apply.
Poisson modeldassumes a constant average rate of
recruitment
23 (46) 13 (68) 36 (52)
Poisson gamma modeldwhich models variability in 13 (26) 8 (42) 21 (30)
(Continued )









n (%) n (%) n (%)
center recruitment rates using a gamma
distribution
Bayesian approaches requiring a prior for
recruitment to be specified
12 (24) 9 (47) 21 (30)
Other 2 (4) 2 (11) 4 (6)
None 24 (48) 4 (21) 28 (41)
8) Have you ever simulated recruitment data to
support your pretrial planning?
Yes, routinely 0 (0) 1 (5) 1 (1)
Sometimes 16 (32) 6 (32) 22 (32)
Never 34 (68) 12 (63) 46 (67)
9) If you do not use any of the approaches
mentioned above for recruitment prediction,
what is the reason for this? Please select all that
apply.
I prefer using a simple approach (e.g., using Excel)
rather than assuming statistical distributions for
recruitment prediction
22 (44) 8 (42) 30 (43)
I am not familiar with these models for recruitment
prediction
17 (34) 2 (11) 19 (28)
I am familiar with some/all of these models, but I
don’t know how to implement them for
recruitment prediction
6 (12) 2 (11) 8 (12)
I am not convinced of the value of implementing
these models
27 (54) 2 (11) 29 (42)
Other 8 (16) 8 (42) 16 (23)
Recruitment monitoring and implementation of
statistical models via Web application
10) How do you routinely monitor recruitment
during the course of a trial? Please select all
that apply.
Tables showing the expected and actual recruitment
rates
43 (86) 14 (74) 57 (83)
Recruitment graphs showing the expected and
actual recruitment rates
49 (98) 11 (58) 60 (87)
Individual recruitment targets for each site 41 (82) 10 (53) 51 (74)
Common recruitment target for all sites 24 (48) 9 (47) 33 (48)
Comparison of overall recruitment rates for each site
with recruitment rate over recent months
31 (62) 8 (42) 39 (57)
Other 8 (16) 0 (0) 8(12)
11) Are you aware of any software/Web platforms
for planning and monitoring patient
recruitment?
Yes 3 (6) 2 (11) 5 (7)
No 47 (94) 17 (89) 64 (93)
12) If a user-friendly Web application
implementing some of the aforementioned
models became freely available, would you be
interested in using it for predicting and/or
monitoring of the trial recruitment? Please
select all that apply.
No, I don’t believe it is a statistical issue, and it is
best handled by the trial team
4 (8) 3 (16) 7 (10)
Not for prediction, but I would be interested in using
it for monitoring
3 (6) 1 (5) 4 (6)
Yes, I want to improve prediction of recruitment 14 (28) 5 (26) 19 (28)
Yes, I want to use it for both initial prediction and
monitoring of recruitment
27 (54) 11 (38) 38 (55)
Other 18 (38) 3 (16) 21 (30)
a Free-text responses have been categorized into common themes.
b Patient and Public Involvement.
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in predicting recruitment (86% UK, 68% ECRIN); howev-
er, statisticians were reported to have been involved in lead-
ing the process in only just over half of the studies.
Respondents from ECRIN reported were less confident than
UK respondents in their awareness of other trials
competing to recruit from the same patient population
(12% UK, 63% ECRIN) and were less likely to adjust for
staggered site openings (96% UK, 68% ECRIN).
Use of statistical models to predict recruitment was low
overall (10%) but higher within ECRIN respondents (6%
UK, 21% ECRIN) who also had greater awareness of the in-
dividual statistical approaches with 48% of UK respondents
not aware of anymethod compared with 21%within ECRIN.
At the pre-trial planning, only 32% of respondents some-
times simulated data to support recruitment prediction,
whereas 67% of them never did (Table 2, Question 8). The
time investigators would need to dedicate to perform simula-
tions is an additional challenge, especially if they are not
convinced of their value.
The majority of respondents who sometimes simulated
data are at least aware of the Poisson model (73%, 16/
22), whereas six of them are not aware of any statistical
model for recruitment prediction (27%, 6/22). On the other
hand, almost half of respondents who never simulated data,
are not aware of any model (48%, 22/46), whereas 43% of
them are at least aware of the Poisson model (20/46).Box 1 Further practices or tools to improve recruitment
Question 13: Please give details of any further practices or tools/re
terms of prediction accuracy in patient recruitment.
 Training (e.g., work with CIs to show the value of involving statistics
trial statisticians/challenge the clinicians, etc.) (8/69, 12%)
 Better engagement (e.g., with potential sites, using standard question
timely input from clinical communities & access to relevant patient g
 Raising awareness of the available approaches (2/69, 3%)
 Current challenges and conflict with NIHR CRN targets (e.g., sites com
they are not challenged/providing the funding for realistic timelines/b
funding/allowing for reallocation of research resources to new studies
 Recommendations to improve prediction (e.g., building up a database
future/use anonymized registry of patients with relevant disease along
incidence and prevalence/comparing predictions and targets to what a
recruitment in pilot studies with that in full trials/getting funders to req
14%)
 Tool/model (a tool that automatically integrates recruitment prediction
for the trial/simple, robust methods yielding accurate results/a smoot
helps to maintain engagement/enthusiasm) (8/69, 12%)
 Demonstrating evidence that these models actually work in practice (e
better than the simpler ways/it can be cumbersome to gather all inform
from a statistician, etc.) (2/69, 3%)
 No response (35/69, 51%)
 Response not clear (3/69, 4%)However, because of the small sample size, we cannot
conclude a definitive correlation between knowledge of sta-
tistical models and use of recruitment simulations.
A sizable proportion of respondents (44% UK, 42%
ECRIN) preferred to use a simple approach rather than sta-
tistical distributions to predict recruitment. Slightly over
half of UK respondents were unconvinced of the value of
implementing these methods in comparison to only 11%
of ECRIN respondents (Table 2, Question 9).
Aminority of respondents were aware of existing software
or Web platforms to support planning and monitoring of pa-
tient recruitment with over a quarter of respondents being
interested in such a resource for predicting recruitment and
over half interested for both prediction and monitoring
(Table 2, Question 12). Free text responses indicated that time
to learn how to use such an application and funderwillingness
to support any associated costs were a concern. Other partic-
ipants expressed an interest in comparing anymethods along-
side those already used in practice to determine whether any
time or resource investment was worthwhile. One participant
expressed concerns on whether the requirements of more
complex clinical trials could be met by such a resource.
Response to the free-text question about further prac-
tices, tools or resources that could potentially improve pre-
diction accuracy are provided in Box 1, with suggestions
for how funders/trial teams could monitor recruitment
progress/milestones summarized in Box 2.prediction
sources that you think could influence your future practice, in
for recruitment purposes before and during the trial/workshops for
naires to elicit proposed recruitment target/easily accessible &
roups, etc.) (5/69, 7%)
e back and ask to change their local recruitment target to ensure
uilding in flexibility with timelines for project management and
toward the end of the study, etc.) (3/69, 4%)
of actual recruitment in our studies that could be referred to in
with demographic information/valid international data on disease
ctually happened so future predictions can be improved/comparing
uest more rigorous methods to estimate recruitment, etc.) (10/69,
s for individual sites in a multicentre trial into an overall prediction
hed time-autocorrelated prediction might be helpful/any tool that
.g., it is important to show that prediction ability of a model/tool is
ation to feed into prediction tools and it would require further input
Box 2 Suggestions for monitoring recruitment progress
Question 14: Do you have any comments or suggestions on how funders/trial teams monitor recruitment progress/milestones?
 Educate funders (e.g., Funders’ expectations of trials set up and recruitment rate should be more realistic/they should be less rigid in
setting targets and monitoring against those targets/funders want more for less/funding panels to define the feasibility of recruitment rates
and convince the administrative funders that studies need more time to be successfully delivered, etc.) (3/69, 4%)
 Educate Chief Investigators (CIs tend to be overoptimistic/Methodologists/statisticians usually try to be conservative but this is challenged
by CIs, etc.) (2/69, 3%)
 Build on skills and experience gained from previous trials (e.g., pass on the skills and experience of trials teams that manage to recruit to
time and budget/ a sort of rule of thumb is that 20-40% of potentially eligible people approached to take part will consent to inclusion/in
cancer trials we tend to expect about 50% of eligible patients to consent etc.) (2/69, 3%)
 Take into account factors related to trial/outcomes/intervention/condition being studied (e.g., seasonal factors/clinic frequency/TTE1
considerations/staggered entry assumptions etc.) (4/69, 6%)
 Allow for delays outside of the control of the trial management team during the course of the trial (e.g., due to budgeting/staffing/re-
sources/new trials opening/delays in agreeing contracts/whole centers dropping out etc.) (2/69, 3%)
 Central database with recruitment information from previous trials to accompany the online tool (1/69, 1%)
 Uncertainty to be considered (e.g., any recruitment estimates at the onset of a trial will be based on assumptions, e.g., average
recruitment rate per site or something similar/there are so many variables involved and I am not sure there are any decent ways of getting
around that/initial recruitment predictions tend to be very inaccurate/any prediction or monitoring of recruitment using sophisticated
modeling may not be any better than using simple projections, etc.) (5/69, 7%)
 Generic programming (programming something generic is important, because statisticians are already under a lot of time pressure and
deadlines, so they want to avoid an overload of duties) (1/69, 1%)
 No response (52/69, 75%)
 Response not clear (3/69, 4%)
1 TTE: time to event.
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This survey is the first to identify current practice on
methods to predict recruitment in clinical trials and raises
hypotheses about different practices in the United Kingdom
compared with Europe and the perceived value of more
complex statistical approaches.
Survey responses clearly indicate that the statistical
models available are not being implemented. The absence
of a robust demonstration of their benefits in comparison
with simple approaches is a key barrier to their uptake.
The statistical literature is restricted to the evaluation of
these models in simulations or in retrospective trials
[7,13,14]. It lacks a real-time prospective evaluation using
the same limited information sources to support parameter
estimation across models at the design stage, which are
then used to monitor actual accrual. Furthermore, the sur-
vey suggested that this evidence is required before trial stat-
isticians being able to justify the time required to
understand and implement the methodology, suggesting
that software availability on its own is insufficient to
change practices.
There are many factors to be taken into account when
predicting recruitment and in turn defining a trial’s dura-
tion. Recruitment targets cannot be realized if based on
overoptimistic expectations and unrealistic timelines. The
overoptimistic expectations of the research team have beenreported previously [15]; however, this survey highlights
the tension felt by a sizable proportion of investigators to
be optimistic about their recruitment rates, for the trial to
be attractive to funders. Despite this tension, there was a
clear appreciation of the difficulties this would cause at
later time points, with calls for funders’ expectations of
trial set up times and recruitment rates to be more realistic,
less rigid and to allow for unforeseen delays outside the
control of the trial management team.
The importance of adhering to the site initiation
schedule is key and our anecdotal experience is that devia-
tions from this often explain a substantial proportion of un-
der recruitment. The time required to complete the
administrative arrangements which need to be made to
open participating sites can vary and be impacted by site
engagement and capacity or by regulatory changes
[16e20]. The survey indicated that staggered site openings
are more commonly allowed for within the United
Kingdom than across the ECRIN network. However,
although the rate of site initiations may be informed by past
experience, there is an inherent assumption regarding the
stability of site resources to deliver the research, remaining
stable throughout the trial. Although a potential solution is
to improve site feasibility and capability assessments, the
variables that need to be included and how they are used
within resulting predictions, needs further scrutiny.
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cians are using a wide variety of information sources to pre-
dict their recruitment rates. However, in practice the
extrapolation of these data to a specific multicenter trial
often requires adjustments to be used. The size of the ad-
justments may be considered to be arbitrary or based on
guess work, and this may in part reduce the number of fac-
tors investigators feel able to include. In addition, as the
availability of routinely collected data increases to support
clinical trial planning, the assessment of such sources and
how they are used will be of increasing importance.
The main focus of our survey was the prediction of
recruitment; however, we also aimed to ascertain how this
was monitored against observed accrual. The responses
demonstrated that this information is considered in multiple
ways per trial with comparisons of observed recruitment
rates against those predicted in graphical or tabular form,
at individual site level and across all sites, and covering
the entire recruitment period or restricting to recent months.
Although eight respondents indicated ‘‘other’’ methods
were used, the free text provided, demonstrated that the
approach was consistent with the closed response cate-
gories. The limitation with these approaches is that they
do not allow understanding of whether the observed varia-
tion is within reasonable limits of the prediction. This may
lead to delays in remedial actions. A potential benefit of us-
ing a statistical model is the prespecification of a quantile to
act as a trigger when the observed recruitment rate is incon-
sistent with that prespecified. One respondent commented
that the use of statistical models would ‘‘simply give a dis-
tribution of recruitment rates from which we would need to
pick a final number which would be the mean, so simple
multiplication would seem as appropriate given the uncer-
tainty about the assumptions.’’ This suggests that even if
the uncertainty they elude to is not welcome within predic-
tion, there is potential for their use within monitoring.
In a survey of the UKCRC-registered CTUs, the top in-
efficiency from recruitment of the first participant to the
publication of results, was identified as the failure to meet
recruitment targets due to overoptimistic or inaccurate
recruitment estimates [21]. Some statisticians reported be-
ing under pressure to project optimistic recruitment rates.
This is likely due to the perception that realistic rates are
associated with increased budgets, beyond what funders
are willing to provide. This issue was raised by our survey
respondents, with participants’ suggestions that training
should be provided for both CIs and funders. Increasing
funders’ flexibility in setting timelines would be helpful
and reflects additional calls on requirements with adaptive
designs [22].
The majority of our respondents believe that a statisti-
cian should be involved in the recruitment prediction pro-
cess but do not model recruitment as a stochastic process.
This may be in part explained by time pressures, as recruit-
ment prediction is undertaken during the unfunded prepara-
tion time of a grant application. This will be compoundedgiven investigators and statisticians are unconvinced that
the models described in the literature are worthy of the
additional time required to support their use. However,
the survey demonstrates the majority would be interested
if the benefits were found to justify the additional time
and statistical expertise required.4.1. Limitations of the studies
This survey aimed to elicit current recruitment practice
across the United Kingdom and Europe. The high-response
rates from the United Kingdom are a strength of the survey;
however, this means that the findings predominantly repre-
sent current practice within the United Kingdom.
The network structure within the United Kingdom facil-
itated survey distribution in a controlled approach using the
network secretariat ensuring a targeted delivery and
response, whereas the ECRIN approach used a more fluid
hub and spoke model where the CIs and the statisticians
were contacted by the EuCos in each country. Other sur-
veys targeting statisticians across the UKCRC CTU
network have achieved similarly high-response rates
[23e25], and we have been unable to identify similar sur-
veys across ECRIN. The lower response rates from ECRIN
may be a result of these different network infrastructures;
however, they may also impacted by the survey being
restricted to the English language.
The comparison of practices between theUnitedKingdom
and Europe therefore needs to be interpreted with caution as
this could reflect response bias within ECRINwith thosewith
particular interests in recruitment prediction taking part. This
may be an explanation for the greater awareness of the statis-
tical methods in the ECRIN respondents.
Furthermore, the investigators in the UK survey were
identified from the website of the largest public funder of
clinical trials in the United Kingdom. The sampling frame-
work for investigators across ECRIN was by identification
of the EuCos and therefore not restricted to a funding
source. However, knowledge of both networks suggests that
the portfolio of studies represented is restricted to noncom-
mercial research. It would be of interest to understand dif-
ferences in methods used in comparison with industry
sponsored studies, with research suggesting recruitment
for industry-sponsored studies being less problematic
[26]. Yet, it is likely that the resources allocated and incen-
tives provided are dissimilar and this complexity of factors
warrants further detailed exploration in future research.5. Conclusions
Approaches used to predict and monitor recruitment
remain frequently unreported, and this survey provides
insight from both statisticians and investigators on methods
and data sources used. This study indicates that the major-
ity of respondents did not recognize recruitment as a
67E. Gkioni et al. / Journal of Clinical Epidemiology 124 (2020) 58e68stochastic process in the approaches used and stated a pref-
erence for using simple approaches. However, they
consider the involvement of statisticians in the recruitment
prediction process to be essential. Simple approaches will
continue to be used despite the advancement of more com-
plex statistical models until their value in improving predic-
tion can be more robustly demonstrated. Until then, their
complexity, time, and training required to aid their imple-
mentation will remain a barrier despite the potential for
their added benefits in monitoring of recruitment.
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